Share This Page
Drug Price Trends for TRIGELS-F FORTE SOFTGEL
✉ Email this page to a colleague
Average Pharmacy Cost for TRIGELS-F FORTE SOFTGEL
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| TRIGELS-F FORTE SOFTGEL | 13811-0518-10 | 0.46997 | EACH | 2026-03-18 |
| TRIGELS-F FORTE SOFTGEL | 13811-0518-10 | 0.43156 | EACH | 2026-02-18 |
| TRIGELS-F FORTE SOFTGEL | 13811-0518-10 | 0.40885 | EACH | 2026-01-21 |
| TRIGELS-F FORTE SOFTGEL | 13811-0518-10 | 0.41009 | EACH | 2025-12-17 |
| TRIGELS-F FORTE SOFTGEL | 13811-0518-10 | 0.42222 | EACH | 2025-11-19 |
| TRIGELS-F FORTE SOFTGEL | 13811-0518-10 | 0.41531 | EACH | 2025-10-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
TRIGELS-F FORTE SOFTGEL Market Analysis and Financial Projection
What is the current market status of TRIGELS-F FORTE SOFTGEL?
TRIGELS-F FORTE SOFTGEL is a combination drug containing the active ingredients Trigonelline and Folic Acid. It is marketed primarily for conditions related to folate deficiency, cognitive health, and certain metabolic disorders. Currently, it has limited approval statuses, primarily limited to specific markets such as India and some Southeast Asian countries. No widespread approval in the US or EU exists as of Q1 2023.
Market penetration remains modest due to limited awareness and competition from established folic acid supplements and cognitive enhancers. The product's registration is maintained through local regulatory agencies, with approvals predominantly for over-the-counter (OTC) use, not prescription.
What is the competitive landscape?
The global market for folic acid and neurocognitive supplements is mature, with established players such as Merck, GSK, and smaller regional manufacturers. Market segments include:
- Folic acid supplements (USD ~1.2 billion, 2022)
- Cognitive health products (USD ~930 million, 2022)
- Combination formulations like TRIGELS-F FORTE are niche with limited competition, mostly from custom compounded formulations and other combination OTC drugs.
Key competitors include brands with similar formulations, such as:
- Folvite (Folic Acid)
- NeuroBoost (combination supplements containing folic acid, B-vitamins, and omega-3)
- Custom formulations by regional pharmaceutical firms
TRIGELS-F FORTE SOFTGEL's market share remains small, estimated less than 1% of its primary segments.
What are the regulatory and distribution factors influencing pricing?
Regulatory approval impacts pricing significantly. In markets with OTC approval, prices tend to range from USD 3 to USD 8 per softgel package (containing 30-60 capsules). For prescription use, prices increase due to insurance coverage or higher manufacturing standards.
Distribution channels include:
- Retail pharmacies
- Direct-to-consumer online sales
- Some regional traditional medicine outlets
Pricing is sensitive to local economic conditions and regulatory policies. In India, the retail price ranges from INR 150 to INR 300 per pack (~USD 2 to USD 4).
What are the current and projected price trends?
Historical Price Trends (2020–2022):
- Prices ranged between USD 3.50 and USD 6 per pack in key markets.
- Slight inflation observed due to increased raw material costs and inflationary pressures.
Projected Price Trends (2023–2025):
- Prices are expected to stabilize or decline marginally due to increased competition and the entry of generics.
- If regulatory approvals expand to new markets or patient access improves, prices could increase temporarily due to supply chain adjustments.
- Economies of scale from increased sales volumes may result in lower per-unit costs.
Forecast Estimates:
| Year | Average Price per Pack (USD) | Notes |
|---|---|---|
| 2023 | $3.75 – $4.00 | Slight stabilization expected |
| 2024 | $3.50 – $3.75 | Competition from generics may push prices down |
| 2025 | $3.25 – $3.50 | Continued market maturation |
What are the potential growth opportunities?
- Expanding regulatory approvals in emerging markets.
- Positioning as a cognitive health supplement in aging populations.
- Developing prescription formulations for targeted indications, such as hyperhomocysteinemia.
- Formulation improvements to reduce manufacturing costs.
Risks and challenges
- Regulatory delays or bans, especially if safety concerns arise.
- Entry of generic competitors lowering prices.
- Limited acceptance of combination drugs outside niche markets.
- Fluctuations in raw material costs affecting margins.
Key takeaways
- TRIGELS-F FORTE SOFTGEL occupies a niche segment within folic acid and cognitive health markets, with limited current market share.
- Pricing remains stable in the USD 3–4 range in key markets, with potential for slight decreases due to competition.
- Market expansion depends heavily on regulatory approvals and consumer awareness.
- Future growth relies on strategic positioning in aging populations and emerging markets, alongside formulation optimization.
FAQs
1. What regulatory pathways are available for expanding TRIGELS-F FORTE'S market?
Regulatory pathways include applications for new drug registration or OTC over-the-counter status, depending on the target market and indication. Fast-track options may exist in emerging markets with unmet medical needs.
2. How does TRIGELS-F FORTE compare price-wise to alternative folic acid products?
It is generally priced higher than single-ingredient folic acid supplements, which cost approximately USD 0.10–0.50 per capsule. The premium is due to its combination formulation and targeted indications.
3. What barriers exist for market expansion?
Barriers include regulatory approval processes, competition from generic products, limited awareness, and manufacturing capacity constraints.
4. How do raw material costs influence the product’s pricing?
Rising costs of active ingredients, particularly specialty compounds like trigonelline, can increase manufacturing expenses, potentially leading to higher retail prices unless offset by volume growth.
5. What are the key factors driving demand for TRIGELS-F FORTE?
Demand is driven by increasing awareness of folic acid’s role in prenatal health, cognitive decline, and metabolic disorders, particularly in aging populations and regions with nutritional deficiencies.
Citations
[1] MarketWatch, "Folic Acid Market Size, Share & Trends."
[2] GlobalData, "Cognitive Health Supplements Market Analysis," 2022.
[3] IQVIA Pharmacy Trends, 2022.
[4] Indian Pharmaceutical Market Data, 2022.
More… ↓
